hotspot -WSS

hotspot

author：entertainment 2025-09-28 22:53:28 - browse：1

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

WSS

The explosion of genetic testing requires a new approach

FDA gives detailed accounting of AI

Lilly's Alzheimer's drug donanemab backed by FDA advisers

UnitedHealth’s board chair also owns a personal investment firm

Solve the antibiotic resistance crisis with preventive drugs

My daughter's legacy lives on through her writing, phage therapy

hotspot

hotspot

focus

Drug repurposing or repositioning? The language matters

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Sports medicine is finally prioritizing gender equality

Study: Why relieving medical debt did not improve financial outcomes

Medical records are filled with copy

Statins may not be needed by millions of people, study suggests

State Dept. review finds Biden bears some blame for Afghanistan failures

Senate committee scrutinizes Medicare Advantage brokers

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Studies point to risks of excluding people with obesity from drug trials

explore

Researchers explore possible ties between long Covid, menopause

Teladoc has a new CEO, but challenges remain the same

California wildfire smoke linked to 52,000 early deaths, study says

CEOs share strategies for surviving biotech slump

Cigna wins case to block Amy Bricker's move to CVS

Researchers explore possible ties between long Covid, menopause

focus

explore

entertainment

hotspot